Literature DB >> 2411288

DNA damage and growth inhibition in cultured human cells by bleomycin congeners.

D E Berry, L H Chang, S M Hecht.   

Abstract

Bleomycin is hypothesized to cause cell growth inhibition and cell death via DNA cleavage. We have attempted to determine if net DNA cleavage is directly related to growth inhibition by measuring whether both parameters vary in parallel. Of primary importance to these studies was use of several bleomycin congeners. We have shown that these congeners vary in their abilities both to inhibit cell growth and to cause DNA damage. Bleomycin B2, tallysomycin, and phleomycin were the most potent growth inhibitors, and bleomycin B2 caused the most DNA damage. N-Acetylbleomycin A2 was inactive in both assays. The net amount of DNA damage measured at two levels of growth inhibition was compared for each congener and was found to vary widely among the congeners. Similarly, the degree of growth inhibition at a given level of submaximal DNA damage was found to vary widely when individual congeners were compared to each other. Hence, growth inhibition and net DNA damage due to bleomycin are not directly correlated with each other when individual congeners are compared to each other.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411288     DOI: 10.1021/bi00334a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Group I intron renders differential susceptibility of Candida albicans to Bleomycin.

Authors:  Prathiba Jayaguru; Malathi Raghunathan
Journal:  Mol Biol Rep       Date:  2006-11-07       Impact factor: 2.316

2.  Growth phase dependency of chromatin cleavage and degradation by bleomycin.

Authors:  C W Moore; C S Jones; L A Wall
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 3.  Mechanisms of bleomycin-induced lung damage.

Authors:  J Hay; S Shahzeidi; G Laurent
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

4.  Site-specific cleavage of RNA by Fe(II).bleomycin.

Authors:  B J Carter; E de Vroom; E C Long; G A van der Marel; J H van Boom; S M Hecht
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Dynamics of bleomycin interaction with a strongly bound hairpin DNA substrate, and implications for cleavage of the bound DNA.

Authors:  Trevor C Bozeman; Rupesh Nanjunda; Chenhong Tang; Yang Liu; Zachary J Segerman; Paul A Zaleski; W David Wilson; Sidney M Hecht
Journal:  J Am Chem Soc       Date:  2012-10-22       Impact factor: 15.419

6.  Precise Small Molecule Degradation of a Noncoding RNA Identifies Cellular Binding Sites and Modulates an Oncogenic Phenotype.

Authors:  Yue Li; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2018-10-30       Impact factor: 5.100

7.  The disaccharide moiety of bleomycin facilitates uptake by cancer cells.

Authors:  Benjamin R Schroeder; M Imran Ghare; Chandrabali Bhattacharya; Rakesh Paul; Zhiqiang Yu; Paul A Zaleski; Trevor C Bozeman; Michael J Rishel; Sidney M Hecht
Journal:  J Am Chem Soc       Date:  2014-09-23       Impact factor: 15.419

8.  Hairpin DNA sequences bound strongly by bleomycin exhibit enhanced double-strand cleavage.

Authors:  Basab Roy; Sidney M Hecht
Journal:  J Am Chem Soc       Date:  2014-03-08       Impact factor: 15.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.